Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 560Neoplasms 504Carcinoma, Non-Small-Cell Lung 421Prostatic Neoplasms 331Colorectal Neoplasms 315Lung Neoplasms 284Neoplasm Metastasis 238Leukemia, Myeloid, Acute 222Ovarian Neoplasms 206Pancreatic Neoplasms 196Multiple Myeloma 186Squamous Cell Carcinoma of Head and Neck 141Stomach Neoplasms 140Recurrence 140Brain Neoplasms 139Melanoma 134Carcinoma, Hepatocellular 132Endometrial Neoplasms 128Glioblastoma 126Precursor Cell Lymphoblastic Leukemia-Lymphoma 117Triple Negative Breast Neoplasms 116Hematologic Neoplasms 104Head and Neck Neoplasms 103Carcinoma, Renal Cell 102Urinary Bladder Neoplasms 99Lymphoma 99Sarcoma 96Glioma 96Esophageal Neoplasms 92Uterine Cervical Neoplasms 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Infectious Mononucleosis × 90 days × Clear all
NCT00032513 2026-06-01

Genetic Studies of Chronic Active Epstein-Barr Disease

National Institutes of Health Clinical Center (CC)

Recruiting
300 enrolled
Lymphoid

Herpes Simplex, Infectious Mononucleosis, Lymphoproliferative Disorders, Virus Diseases, Epstein-Barr Virus Infections

NCT06908096 2026-05-18

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
750 enrolled

Infectious Mononucleosis, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡